➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson

Last Updated: July 26, 2021

DrugPatentWatch Database Preview

Xiromed Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for XIROMED, and what generic and branded alternatives to XIROMED drugs are available?

XIROMED has thirty-one approved drugs.

Summary for Xiromed
US Patents:0

Drugs and US Patents for Xiromed

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xiromed MIDODRINE HYDROCHLORIDE midodrine hydrochloride TABLET;ORAL 207849-001 Oct 1, 2020 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Xiromed ELIFEMME ethinyl estradiol; levonorgestrel TABLET;ORAL-28 202507-001 Dec 4, 2015 DISCN No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Xiromed PROGESTERONE progesterone CAPSULE;ORAL 205229-001 Oct 20, 2017 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
Xiromed DARIFENACIN HYDROBROMIDE darifenacin hydrobromide TABLET, EXTENDED RELEASE;ORAL 209571-001 Oct 22, 2019 AB RX No No ⤷  Free Forever Trial ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Paragraph IV (Patent) Challenges for XIROMED drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.